How Flurpiridaz Will Change Cardiac PET Imaging
April 27, 2020
While PET MPI has seen increased interest among cardiologists, financial constraints and availability concerns have kept the modality from gaining traction in the US market. The current set of radiopharmaceuticals has built-in drawbacks, but recent innovations could change that. 18F Flurpiridaz is a new agent is showing considerable promise –
